Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265481 · ClinicalTrials.gov registry record · NA
The Effect of Tapping in the Venous Dilatation for Peripheral IV Access
A NA study of Catheterization, Peripheral and Venous Dilatation, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05265481: Completed NA study of Catheterization, Peripheral and Venous Dilatation, sponsored by University of Florida.
NCT05265481 is a NA study of Catheterization, Peripheral and Venous Dilatation that has completed, run by University of Florida. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05265481, a NA study of Catheterization, Peripheral and Venous Dilatation, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral intravenous cannulation (PIVC) is one of the most common interventions in medical practice. Venous dilatation is helpful for successful PIV placement. Several techniques include hot pack application, tourniquet, massaging, and tapping over the vein to increase vein caliber described in the literature. However, none of them has been rigorously studied. Therefore, there is still no 'best practice' on how to effect vein dilation in a standard way. This study aims to investigate the effect of standardized tapping on venous dilatation with a massage device compared to manual non-standardized tapping and define a standard tapping technique using a device. In this study, the investigators also aim to investigate the effect of tourniquet application with and without vein tapping effect on peripheral vein caliber as determined by ultrasound measurement.
Primary Outcome
The primary outcome is to measure the vein diameters after manual and device tapping and detect the change from baseline in vein diameters.
Conditions Studied
Interventions
- DEVICE Tourniquet
- DEVICE Manual Tapping
- DEVICE Device tapping
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-11-07 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT05265481 record still lists
NCT05265481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Catheterization, Peripheral appearing as the primary indexed condition, and to 3 interventions - of which Tourniquet is the first listed.
NCT05265481 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05265481 about?
NCT05265481 is a clinical study titled "The Effect of Tapping in the Venous Dilatation for Peripheral IV Access". Peripheral intravenous cannulation (PIVC) is one of the most common interventions in medical practice. Venous dilatation is helpful for successful PIV placement. Several techniques include hot pack application, tourniquet, massaging, and tapping over the vein to increase vein caliber described in th...
What is the current status of trial NCT05265481?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-11-07. Estimated completion is 2022-06-01.
What conditions does trial NCT05265481 study?
This clinical trial studies the following conditions: Catheterization, Peripheral, Venous Dilatation.
What interventions are being tested in trial NCT05265481?
The interventions under investigation include: Tourniquet (DEVICE), Manual Tapping (DEVICE), Device tapping (DEVICE).
Who is sponsoring clinical trial NCT05265481?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05265481 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheterization, Peripheral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05265481's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI